What is LOPJLB’s current signal on FLNA?

LOPJLB’s latest quantitative signal on Filana Therapeutics, Inc. (FLNA) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is FLNA in?

Filana Therapeutics, Inc. (FLNA) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Filana Therapeutics, Inc. (FLNA) do?

Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.